Related Experiment Video
Updated: Jun 10, 2026
10:16
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
Quantum dots as contrast agents for in vivo tumor imaging: progress and issues
Anthony J Tavares1, Lori Chong, Eleonora Petryayeva
1Chemical Sensors Group, Department of Chemical and Physical Sciences, University of Toronto Mississauga, ON, Canada.
Analytical and Bioanalytical Chemistry
|July 27, 2010
Summary
Quantum dots (QDs) offer promising fluorescence imaging for diseases. Modifications with peptides and proteins enhance tissue targeting for in vivo tumor imaging and reduced toxicity.
Area of Science:
- Biomedical imaging
- Nanotechnology
- Molecular biology
Background:
- Quantum dots (QDs) are nanomaterials with unique optical properties.
- QDs show potential for biomedical applications, including disease research.
- Targeted delivery is crucial for effective in vivo imaging.
Purpose of the Study:
- To review QD design and modification strategies for targeted fluorescence imaging.
- To highlight the use of peptides and proteins for tissue-specific QD delivery.
- To discuss the in vivo distribution, fate, and toxicity considerations of QDs.
Main Methods:
- Literature review of recent studies on QD-based imaging.
- Analysis of QD modification techniques using peptides and proteins.
- Evaluation of in vivo studies demonstrating QD targeting and imaging efficacy.
Main Results:
- Peptide and protein modifications enable specific targeting of tissues for imaging.
- QDs demonstrate potential as effective fluorescence imaging agents in vivo.
- Studies illustrate successful in vivo tumor imaging using targeted QDs.
Conclusions:
- Engineered QDs with peptide/protein conjugates are valuable tools for in vivo fluorescence imaging.
- Targeted QD designs can improve diagnostic accuracy in cancer and other diseases.
- Minimizing QD toxicity through design is essential for clinical translation.
